Closing Bell: Nervgen Pharma Corp up on Friday (NGEN)

Today during trading, Nervgen Pharma Corp shares closed at $2.00 after opening the day at $1.85. prices ranged from $1.85 to $2.04.

The price gained 7.53 percent from the previous day's close of $1.86.

Today across North America, the TSX Composite closed -1.00% at 22007.00, the S&P 500 closed -0.02% at 5352.96, the Dow Jones Industrial Average closed 0.20% at 38886.17 and the Nasdaq Composite closed -0.09% at 17173.12.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

A total of 122,140 shares was traded during the last trading day, with total trades of 221. On average, Nervgen Pharma Corp has traded 65,557 shares over 5 days and 86,164 year-to-date.

The TSX-V market on the whole today saw 1,416 price advancers against 3,737 declines and 104 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 52 weeks, Nervgen Pharma Corp's shares have advanced 16.28%, while this year, they have shrunken -25.93%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $130.06 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..